Business Description
BG Medicine Inc
NAICS : 621511
SIC : 2835
ISIN : US08861T2069
Compare
Compare
Traded in other countries / regions
BGMD.USA IPO Date
2011-02-04Description
BG Medicine Inc is a diagnostics company focused on the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of cardiovascular events, such as heart attack and ischemic stroke.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -234.16 | |||||
OCF Margin % | -234.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BGMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BG Medicine Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.566 | ||
| EPS (TTM) ($) | -0.72 | ||
| Beta | -73.1413 | ||
| 3-Year Sharpe Ratio | -61.75 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 11.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BG Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BG Medicine Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.25:1 Stock Split | 2015-07-09 | 1.70 (-7.81%) |
Show
Entries
BG Medicine Inc Frequently Asked Questions
What is BG Medicine Inc(BGMD)'s stock price today?
The current price of BGMD is $0.00. The 52 week high of BGMD is $0.00 and 52 week low is $0.00.
When is next earnings date of BG Medicine Inc(BGMD)?
The next earnings date of BG Medicine Inc(BGMD) is .
Does BG Medicine Inc(BGMD) pay dividends? If so, how much?
BG Medicine Inc(BGMD) does not pay dividend.
Guru Commentaries on OTCPK:BGMD
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BG Medicine Inc
No articles.